Editorial

Current Biology at 20
As 2010 draws to a close, Current Biology completes its twentieth year of publication -were the journal a person, it would turn 20 with the new year, but as journals are deemed to be age (volume) one in their first year, the volume number is one ahead of the chronological age. All of which is by way of a long-winded justification for writing about this anniversary now, rather than at the beginning of the year.
I think journal editors can overestimate the level of outside interest and excitement about their journal's anniversary, but nevertheless I will take this opportunity to say something about the journal and its history, which is somewhat unusual. As Peter Newmark, our founder, recounts below, Current Biology started life, in 1991, as a bi-monthly tertiary journal, publishing commentaries (dispatches) on recent advances in -to use the journal's then-stated description -"modern" biology, by which it meant biology in the "new" molecular tradition. If you look over early issues of the journal you will note a rather distinctive visual style, with curious occasional woodcuts and cartoons, and plenty of (then unusual) computerdrawn colour illustrations (some impression of our early style is given by the cover of our first issue, shown in the figure).
The journal was owned originally by the Current Science group, which also published the biological Current Opinion journals. This was a relatively small, privately owned publishing company, which put a lot of emphasis on innovation and the use of computer technology -hence the extensive computer graphics and computer-based typesetting -all old-hat now, but back then just coming into publishing (in my 11 years at Nature, I never had use of a computer).
I joined the journal, from Nature (like Peter Newmark), in 1992, and we took the opportunity to turn Current Biology into a primary journal -I cannot think of another review journal that has transformed to one (also) publishing research papers. In retrospect, we were overly optimistic about the speed with which we would take off and become, as we hoped, one of the 'top' primary journals in biology. The initial rate of submissions was rather low, and for several years we published just a few papers per issue -we had the luxury of being able to do this because of our extensive, popular dispatch section, which had already attracted a significant following.
We were somewhat naive in believing that, by being new, looking good and having extensive experience and a large network of contacts from working at Nature, we would have no trouble attracting authors with exciting results to report. It is clear now that this was not sufficient. It is very hard to get a general journal off the ground when you are by definition not aiming at a specific subject niche and without some strong backing force, as benefited the Public Library of Science, which started a journal with similar scope on the back of the open access movement.
Our emphasis was not on niche or business model, but rather on quality of editorial service, and quality of product.
Peer review remains a constant topic of discussion: we have always been of the view that the issue is not whether to have peer review or some alternative, but how to ensure that the quality of peer review -and editorial decision making -is as good as possible.
In particular, we wanted to be fast in our assessments of papers, and so far as possible to avoid making arbitrary editorial decisions after prolonged technical review of a paper -this is the reasoning behind our strong emphasis on 'presubmission enquiries'. Popular general journals attract far more technically adequate papers than they can publish; decisions have to be made about the level of interest, the degree of advance, etc. To a large extent, such decisions can be made prior to time-consuming formal review of the full paper on the basis of a presubmission enquiry with an abstract that makes clear what the new work adds to the field.
The second pillar on which we hoped to build was the extensive 'front matter' section, which started, as mentioned, with the dispatches, but has subsequently
The cover of the first issue of Current Biology. The general subject headings -Cell Biology, Neurobiology, Immunology, Structural Biology and Genetics & Development -and the associated colours were taken from the equivalent Current Opinion journals.
How it all began
I can't recall if it was the morning or the afternoon of my first day in my new job that my boss said he thought it would be a good idea to start a journal to rival Nature, albeit only on the biology side. After pausing to gulp, I said "Yes, but….".
My boss was entrepreneurial publisher Vitek Tracz. My job was that of Managing Director of Current Biology Ltd., a newly formed company that had two Current Opinion titles as its starting point. I had taken the job after 16 years at Nature so, naturally, Vitek felt I should be able easily to start a rival.
After a little, or perhaps a lot, of discussion about the problems of starting from scratch a high-profile journal containing all the elements of Nature, we settled on a rather less ambitious starting point. This was to publish mini-reviews with the aim of bettering the most-read section of Nature -its News and Views. We decided to start by publishing them every other month during 1991 and giving the journal away free to every subscriber to a Current Opinion journal as well as to several thousand high-ranking biologists. This would build up visibility and, we hoped, popularity so that we could then start to sell subscriptions, increase the frequency and, at some stage, perhaps, start publishing research papers.
We kicked around many ideas for a title but in the end couldn't come up with anything that seemed more to the point than "Current Biology". For the mini-reviews we came up with "Dispatches". And for the journal as a whole we coined the slogan "Dispatches from the frontlines of Biology". Twentyfour dispatches were to be commissioned for each issue, with four coming from each of the six areas of biology that had been defined by the Current Opinion series. They were to be heavily edited and illustrated in innovative ways and in colour. I commissioned the content. To help me edit it, I hired Kate Hooper, an editor from Nature. Celia Welcomme, who had brilliantly illustrated the then best-selling immunology text book ('Roitt') created the style of illustration. Vitek, himself, provided the creative input for the design of each cover.
Current Biology kicked off in February 1991 and by the end of the year it was clear that we had a success on our hands and several thousand subscribers. This led us to turn it into a monthly subscription journal, at which point I decided I needed a Deputy Editor, a role filled by the current Editor, Geoffrey North, in May 1992. By then, the shall we? / shan't we? discussions had been resolved -we would start publishing research papers from the start of 1993.
Peter Newmark Founding Editor
grown to include all of the formats that are now gathered under our "magazine" section, including Primers, Quick guides, Q&As, Essays and news articles, in addition to the dispatches and full reviews/minireviews. Our aim has been for our readers to be able to learn about the major developments in any area of biology, and to be able to learn about new fields.
We also try to divert and surprise; for example, many of our Quick Guides point out features of a particular species that may be underappreciated -such as the one we published on locusts [1] , with their remarkable solitarygregarious polyphenism (as the switch to the gregarious form is inherited, I am surprised it is not the focus of more interest and excitement among those working on 'epigenetic' mechanisms -on which more below). Or with a correspondence item that analysed early video footage and made inferences about the prevalence of lefthandedness in the Victorian era. As mentioned in a piece I wrote last year [2] , this feeling that journals benefit from 'leavening' was inherited from my Nature editor, the late John Maddox.
Another aspect of the philosophy that continues to guide Current Biology is our interest in all the levels of analysis in biology -from biochemical and molecular to ecosystem. We are strong in our view that the purpose of biological research is not solely to elucidate "mechanisms". This may be most evident in our interest (and strength) in the fields of cognitive science and animal behaviour, with the view that such research has great intrinsic merit in establishing what it is that the brains of human and other organisms actually do -and why. For those who might be interested, I say more about this in the foreword to the Cold Spring Harbor monograph on invertebrate neuroscience that I co-edited a few years ago [3] .
These approaches and efforts would seem to have worked -the journal was acquired by Elsevier in 1998, and moved to Cell Press in 2001, and we are now offered thousands of papers a year, and have an impact factor in double figures. Beyond these simple figures we have a strong following of readers in many fields who appreciate our approach and who like the journal.
But what of the state of biology in 2010? I am not going to say we "live in exciting times" -it is too trite, too often said to be very meaningful. There is a vast amount of interesting biological research being done, and the amount of new "data" that will be acquired in 2011 will be much higher than 50 years ago (1961) -but will the essential advance in biological understanding really be greater than in a year that saw publication of Jacob and Monod's operon model, the great paper on the triplet genetic code by Crick, Brenner and colleagues, and the evidence proving the existence of messenger RNA?
Unlikely, I think. Biology is at a very different stage now than 50 years ago. The fundamental principles of molecular biology have been worked out -we now understand how biological information is stored, expressed and transmitted -and much of the present work, in molecular and cellular fields at least, is concerned with details of how the expressed information gives rise to specific aspects of the phenotype. As my colleague Florian Maderspacher [4] argued recently in Current Biology, despite attempts of some in the media, there is not going to be a new revolution that leads to "victory over the gene", and it seems highly unlikely to me that it will turn out that a significant amount of heritable information is stored "beyond the genome" [5] .
The premature declarations of "victory over the gene" illustrate a curious phenomenon that seems to bedevil biology: and that is the problem that certain words seem to acquire a fashionable gloss at the same time that they lose clear meaning. This is seen repeatedly -most notably in recent years for the terms "systems biology" and "epigenetics". In the first case, one sees perfectly respectable departments of cell biology (for example), homes to excellent labs doing great work combining experimental approaches with appropriate quantitative theory, all of a sudden renaming themselves as departments of systems biology, for no substantive reason, thereby bracketing their research with bioinformatic studies of the kind largely concerned with analysing data (often of unclear significance) derived from "high throughput", genomics-related studies. That said, the move to make cell and developmental biology more quantitative, to try to understand how the components interact to give global properties that are not always intuitively obvious, is clearly a good thing [6] . The important thing, it seems to me, is to have a clear, specific question in mind and not just generate a large amount of data and throw up your hands saying "what does it all mean?"
The term "epigenetics" seems to be a source of endless confusion, a term applied variously to all modifications of DNA or associated proteins, to transcriptional "memory" (as classically exemplified by the lysogenic state of the phage lambda), to characteristics inherited across generations that are shown to be independent of the genomic DNA sequence. Conferences that, in past years, were content to declare their subject as "transcriptional regulation" now invariably have to incorporate "epigenetics" somewhere into their title. One can only hope that, as the fashionable gloss fades with time, clarity will reassert itself -at Current Biology we shall continue to try to help clarify such matters, as for example with the essay we published a few years ago on the use of the word "epigenetics" [7] .
At risk of seemingly overly didactic, there is a point worth emphasising that is relevant to discussions of epigenetics and (heritable) "information beyond the genome". This is illustrated by the locust example mentioned briefly above; such cases of inherited polyphenism are not examples of Lamarckian evolution -the locust genome itself encodes the potential to make two stable phenotypes, either the gregarious form or the solitary one. Plasticity is very common in biology, from lambda's ability to be either lysogenic or lytic, to plants that grow in different ways in response to variations in the environment and nervous systems that can learn. Such plasticity can be predictive; this is clearly shown by circadian systems, which make changes to optimise phenotypes for future conditions. And, in the case of inherited polyphenisms, these "predictions" are passed across generations. The prediction has to have a physical implementation, which is reasonably described as "epigenetic", and could involve some chemical modification of DNA, RNA or associated proteins, or involve tightly bound proteins -whatever the actual mechanism, it is, in a sense, storing information, but it is not independent of ("beyond") the genome.
Despite my doubts about whether 2011 will match 1961 for fundamental advances in understanding, I do think that there is much of great interest in current biology. The relationship between genetic information and phenotype is complex business, and a proper understanding of why cells behave as they do, and how the collections of cells generated by a fertilised oocyte have the form and properties that they have, will require not only chemistry and genetics but physics, the application of which to cell and developmental biology is gradually increasing.
The brain remains a great frontier of biology, given that there is so much that is still very poorly understood. Significant advances are of course being made, such as in functional imaging and "optogenetics" [8] , where genetic transformation allows optical control of activity in specific neurons. There is still I think, in studies of "higher" brains, most particularly the human brain, a sense of the blind men studying the elephant by touch. This is of course one justification for studying smaller brains, particularly those of invertebrates, which despite their size can control a highly sophisticated behavioural repertoire [9] -the notion that just because an animal lacks a backbone it must be "simple" is a myth, as unjustified as the pejorative use of the epithet "bird-brained".
But, mystery is good; it is good to know things, but it is thrilling to know that we have much to learn -while it seems unlikely we shall see a year quite like molecular biology's annus mirabilis, 1961, again, there will surely be many exciting new developments to report and explain in Current Biology in the years to come.
